Click Here for 5% Off Your First Aladdin Purchase!

AS601245 - ≥95%, high purity , CAS No.345987-15-7, Inhibitor of mitogen-activated protein kinase 10

  • ≥95%
Item Number
A275935
Grouped product items
SKUSizeAvailabilityPrice Qty
A275935-1mg
1mg
In stock
$28.90
A275935-5mg
5mg
In stock
$117.90
A275935-10mg
10mg
In stock
$206.90
A275935-25mg
25mg
In stock
$465.90
A275935-50mg
50mg
In stock
$800.90
A275935-100mg
100mg
In stock
$1,335.90

Potent, selective, ATP competitive JNK inhibitor. Cell-permeable.

Basic Description

SynonymsAS601245|345987-15-7|AS-601245|1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile|2-(benzo[d]thiazol-2-yl)-2-(2-((2-(pyridin-3-yl)ethyl)amino)pyrimidin-4-yl)acetonitrile|2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamin
Specifications & Purity≥95%
Storage TempStore at -20°C,Desiccated
Shipped InDry ice
Action TypeINHIBITOR
Mechanism of actionInhibitor of mitogen-activated protein kinase 10
Product Description

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.


product description:

A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration. 


Biochemical mechanism:

Cell permeable: yes

Product competes with ATP.

Primary Target

hJNK 1, hJNK 2, hJNK 3

Reversible: yes

Target IC50: 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively

Associated Targets

MAPK10 Tchem Mitogen-activated protein kinase 10 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-(1,3-benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile
INCHI InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)
InChi Key RCYPVQCPYKNSTG-UHFFFAOYSA-N
Canonical SMILES C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4
Isomeric SMILES C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4
PubChem CID 10109823
Molecular Weight 372.45

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

6 results found

Lot NumberCertificate TypeDateItem
B2318670Certificate of AnalysisDec 21, 2023 A275935
B2318673Certificate of AnalysisDec 21, 2023 A275935
B2318688Certificate of AnalysisDec 21, 2023 A275935
B2318823Certificate of AnalysisDec 21, 2023 A275935
B2318880Certificate of AnalysisDec 21, 2023 A275935
B2318885Certificate of AnalysisDec 21, 2023 A275935

Chemical and Physical Properties

SolubilitySoluble in DMSO to 25 mM

Related Documents

References

1. Gaillard P, Jeanclaude-Etter I, Ardissone V, Arkinstall S, Cambet Y, Camps M, Chabert C, Church D, Cirillo R, Gretener D et al..  (2005)  Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase..  J Med Chem,  48  (14): (4596-607).  [PMID:15999997]
2. Ivshina MP et al..  (2022)  CPEB1 regulates the inflammatory immune response, phagocytosis, and alternative polyadenylation in microglia..  Glia,  70  (10): (1850-1863).  [PMID:35635122]

Solution Calculators